HSV-2 is contagious, and it spreads through direct skin-to-skin contact during vaginal, anal, or oral sex. What surprises most people is that transmission doesn’t require visible sores. An estimated 70% of HSV-2 transmissions happen during periods when the infected person has no symptoms at all and may not even know they carry the virus.
How HSV-2 Spreads
The virus passes from one person to another through contact with genital or anal skin, sores, or genital fluids from someone who has the infection. It can also spread through contact with the oral area, though HSV-2 strongly prefers the genital region and is far less commonly transmitted to or from the mouth.
You don’t need to touch an open sore to contract it. HSV-2 can be transmitted when the skin looks completely normal. The virus periodically travels to the surface of the skin and becomes active at levels high enough to infect a partner, even when no sore, tingle, or redness is present. This process, called asymptomatic shedding, is the primary driver of new infections.
It’s also possible to spread HSV-2 to other parts of your own body. Touching a sore and then touching your eyes, for example, can transfer the virus. This is uncommon but worth knowing about, especially during a first outbreak when viral levels tend to be highest.
Transmission Risk by the Numbers
In studies tracking couples where one partner has HSV-2 and the other doesn’t, the annual transmission rate runs around 10% when no preventive measures are used. The risk isn’t equal in both directions. In one study following these couples for roughly a year, 16.9% of female partners acquired HSV-2 from an infected male partner, while only 3.8% of male partners acquired it from an infected female partner. Male-to-female transmission is significantly more efficient, likely because of differences in mucosal surface area exposed during sex.
These are per-year figures, not per-encounter. The risk from any single sexual contact is much lower, but it accumulates over time in an ongoing relationship.
Why It Spreads Without Symptoms
HSV-2 is most contagious when sores are present, but the virus doesn’t limit itself to outbreaks. Between episodes, the virus lives dormant in nerve cells near the base of the spine. Periodically, it reactivates and travels back to the skin surface in small amounts. During these episodes, a person sheds enough virus to infect a partner without ever feeling anything unusual.
People who have been diagnosed with symptomatic genital herpes shed the virus more often than those who carry HSV-2 without knowing it. Those who have never had noticeable symptoms shed about 50% less frequently. But “less frequently” still means the virus reaches the skin surface on some days, which is why someone who has never had a visible outbreak can still pass the infection to a partner.
Condoms Help but Don’t Eliminate Risk
Consistent condom use reduces HSV-2 transmission, but the protection is incomplete. The virus can spread through contact with genital or anal skin that a condom doesn’t cover, including the upper thighs, pubic area, and buttocks. One study found that regular condom use provided strong protection for women acquiring HSV-2 (roughly a 90% reduction in risk), though the same protective effect was not seen for men acquiring the virus from female partners. The difference likely comes down to anatomy: condoms cover more of the skin involved in male-to-female transmission than in the reverse direction.
How Antiviral Medication Lowers Risk
Daily suppressive antiviral therapy significantly reduces both outbreaks and transmission. Taking a daily antiviral cuts outbreaks by 70% to 80% in people who have frequent recurrences, and it also reduces viral shedding on the days between outbreaks. In discordant couples (where one partner is positive and the other negative), daily suppressive treatment has been shown to lower the rate of transmission to the uninfected partner.
Combining daily antiviral therapy with consistent condom use offers the strongest protection currently available. Neither method is perfect alone, but together they substantially reduce the odds of passing HSV-2 to a partner.
Risk During Pregnancy and Childbirth
HSV-2 can pass from mother to baby during delivery, though the risk varies dramatically depending on timing. The highest risk applies to women who acquire a new HSV-2 infection late in pregnancy. Because their immune system hasn’t yet built antibodies against the virus, viral levels tend to be high during delivery. In this scenario, the transmission rate is roughly 1 in 1,900 births.
Women who already carried HSV-2 before pregnancy have a much lower risk, around 2 in 5,761 births. Their immune system has already developed antibodies that help suppress the virus and provide some passive protection to the baby. For women with a known history of genital herpes, doctors typically prescribe suppressive antiviral therapy in the final weeks of pregnancy and check for active lesions at the time of delivery.
The Takeaway on Contagion
HSV-2 is contagious during outbreaks and between them. The virus sheds from normal-looking skin, spreads through direct contact rather than through surfaces or the air, and passes most efficiently during vaginal or anal sex. Daily antiviral medication and consistent condom use both reduce transmission risk, and combining them offers the most protection. Knowing that the majority of transmissions happen when no symptoms are visible is the single most important fact for anyone managing or trying to prevent HSV-2.